IQ SOLUTIONS, INC. - CDER PHASE II BIOSIMILARS: EDUCATION AND OUTREACH INITIATIVE

PIID: 75F40122F80219
Signed Date: Jul 21, 2022Effective Date: Jul 21, 2022End Date: Closed on Jun 30, 2026
Award $
$1.5M
Vendor
IQ SOLUTIONS, INC.
NAICS
541613
Signed Date
Jul 21, 2022

Key Details

Dollars Obligated
$1.5M
Base & All Options
$1.5M
Awarding Sub-Agency
Food and Drug Administration
Contract Vehicle
GSA MAS (legacy)
Parent IDIQ (PIID)
GS00F083CA
Product Service Code
B542 - SPECIAL STUDIES/ANALYSIS- EDUCATIONAL
Extent Competed
FULL AND OPEN COMPETITION
Number of Offers
4
Place of Performance
SILVER SPRING, MD

Description

CDER PHASE II BIOSIMILARS: EDUCATION AND OUTREACH INITIATIVE

Context & Analysis

On Jul 21, 2022, Department of Health and Human Services obligated $1,546,066 to IQ SOLUTIONS, INC. for cder phase ii biosimilars: education and outreach initiative. The award is classified under NAICS 541613 — MARKETING CONSULTING SERVICES. Competition extent: full and open competition with 4 offers received. Performance is located in SILVER SPRING, MD. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541613 — related awards are listed below.

Contractor Information

Contractor: IQ SOLUTIONS, INC.
UEI: HKS1BN6QXJ95
Location: NORTH BETHESDA, MD

Stay Updated

Get notified about new opportunities matching your interests.

Related